BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16675572)

  • 1. Prognostic DNA methylation biomarkers in ovarian cancer.
    Wei SH; Balch C; Paik HH; Kim YS; Baldwin RL; Liyanarachchi S; Li L; Wang Z; Wan JC; Davuluri RV; Karlan BY; Gifford G; Brown R; Kim S; Huang TH; Nephew KP
    Clin Cancer Res; 2006 May; 12(9):2788-94. PubMed ID: 16675572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
    Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
    Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
    Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
    Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
    Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
    Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic sweeping for hypermethylated genes.
    Goh L; Murphy SK; Muhkerjee S; Furey TS
    Bioinformatics; 2007 Feb; 23(3):281-8. PubMed ID: 17148511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer.
    Duncan TJ; Rolland P; Deen S; Scott IV; Liu DT; Spendlove I; Durrant LG
    Clin Cancer Res; 2007 Jul; 13(14):4139-45. PubMed ID: 17634541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
    de Maat MF; van de Velde CJ; van der Werff MP; Putter H; Umetani N; Klein-Kranenbarg EM; Turner RR; van Krieken JH; Bilchik A; Tollenaar RA; Hoon DS
    J Clin Oncol; 2008 May; 26(14):2327-35. PubMed ID: 18467724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis.
    Mhawech-Fauceglia P; Herrmann FR; Andrews C; South S; Beck A; Lele S; Odunsi K
    Eur J Surg Oncol; 2009 Jul; 35(7):763-7. PubMed ID: 19081223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
    Barton CA; Hacker NF; Clark SJ; O'Brien PM
    Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
    Meinhold-Heerlein I; Bauerschlag D; Zhou Y; Sapinoso LM; Ching K; Frierson H; Bräutigam K; Sehouli J; Stickeler E; Könsgen D; Hilpert F; von Kaisenberg CS; Pfisterer J; Bauknecht T; Jonat W; Arnold N; Hampton GM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):458-66. PubMed ID: 17255266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated algorithm for gene selection and classification applied to microarray data of ovarian cancer.
    Lee ZJ
    Artif Intell Med; 2008 Jan; 42(1):81-93. PubMed ID: 18006289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
    Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
    Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling studies in ovarian cancer: a review.
    Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
    Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.